1. <dfn id="8ngdu"></dfn>

      1. <dfn id="8ngdu"></dfn>
        <rp id="8ngdu"><address id="8ngdu"></address></rp>
          <video id="8ngdu"><menu id="8ngdu"><kbd id="8ngdu"></kbd></menu></video>

          1. <b id="8ngdu"></b>

          Chemicals
          CIRS Group
          Chemicals
          Cosmetic
          Food
          Medical Devices
          Agrochemicals
          CIRS Testing
          Carbon Neutrality
          Search

          ECHA Publishes 2024 Annual Work Report

          from CIRS by

          In April 2025, the European Chemicals Agency (ECHA) released its 2024 annual work report, showcasing its significant achievements and challenges in chemical regulation over the past year. Here are the key highlights:

          1. Dossier Preparation

          In 2024, ECHA processed numerous data-sharing consultations and disputes in compliance with regulations, achieving a 14% year-on-year increase in processing volume to ensure efficient operations. It also provided full-cycle tool support and professional guidance for enterprises' information registration and updates.

          IndicatorsEstimateActual
          Inquiries received and concluded4,8005,491

          ECHA co-hosted its first IUCLID and eChemPortal International Coordination Conference with the OECD, addressing global chemical data exchange standardization challenges and promoting cross-border data management consensus. It upgraded the IUCLID system, adding modules like format validation for EU and international regulatory requirements and smart filtering. ECHA also participated in the OECD Test Guidelines Experts Working Group to support the development of technical standards in key areas and enhance the international chemical regulatory system.

          2. Dossier Submission and Processing

          In 2024, ECHA optimized processes and tools to efficiently handle enterprise-submitted dossiers under the REACH and CLP frameworks, with a surge in C&L notifications due to batch submissions and automated transmission. All registration dossiers underwent completeness checks, with one-third subject to manual verification. The number of enterprise-submitted dossiers was lower than expected, but data completeness improved significantly. The number of registration cases failing the first-tier technical completeness check (669) was much lower than the estimated 1,300 based on historical data. An appeal against a completeness check decision was rejected, validating ECHA's enforcement approach.

          IndicatorsEstimateActual
          Number of PPORD notifications received240238
          Number of C&L notifications received35,000168,990
          Number of Registration dossiers received (incl. updates)15,00013,470
          Registrations stopped for manual verification at the technical completeness check5,1004,206
          Number of registrations failing the first technical completeness check1,300669
          Number of confidentiality assessments concluded220241
          Number of revocations or invalidations concluded150126

          ECHA initiated an industry-submission system integration plan, piloting with DWD drinking water data reporting to build a unified portal platform for streamlined enterprise dossier submission.

          3. Identification and Prioritisation

          In 2024, ECHA restructured the International Regulatory Strategy (IRS) with the EU Commission and member states, establishing new objectives centered on intelligent chemical database management and substance-group risk control. Through cross-framework collaboration with other agencies such as EFSA, and EMA, it implemented the "one substance, one assessment" integrated regulatory model on the RIME + platform, achieving three key breakthroughs.

          IndicatorsEstimateActual
          Number of groups of substances for which a preliminary conclusion on potential regulatory follow-up was drawn or further clarified4047

          4. Evaluation

          In 2024, ECHA completed the rectification of the 2023 joint evaluation plan, established a new compliance review mechanism, and met the 2024 evaluation targets. It improved case-handling efficiency by 300% through collaboration with member state regulatory agencies and set up an evaluation decision-response tracking system to ensure 100% compliance of enterprise-submitted data.

          IndicatorsEstimateActual
          Compliance checks concluded: draft decisions or no action250251
          Final decisions on dossier evaluation (testing proposals and compliance checks) 250300
          Number of substances for which a conclusion was reached in the follow-up to the dossier evaluation250219

          ECHA updated the CoRAP list with 25 new substances for assessment and completed 19 substance evaluation conclusions. Its support mechanism for member state assessment agencies achieved a 92% satisfaction rate.

          IndicatorsEstimateActual
          Substance evaluation final decisions issued103
          Number of substances for which a conclusion was reached in a substance evaluation 2519

          5. Authorisation

          In 2024, ECHA updated the Substance of Very High Concern (SVHC) candidate list, adding two environmental endocrine disruptors (totaling 242), and upgraded data standards for one existing substance. Despite a sharp decline in authorisation applications to 43, the scientific committee faced a structural imbalance between assessment capacity and application volume. There were only 766 downstream user SVHC usage notifications, falling short of the estimated 3,000.

          IndicatorsEstimateActual
          Number of new entries in the Candidate List152
          Applications and review reports for authorisation received (number of uses) 40-6057
          Number of downstream user notifications of authorised uses of SVHCs3000766
          Number of RAC and SEAC opinions adopted on applications for authorisation (number of uses)4055

          6. Restrictions

          In 2024, ECHA completed full-chain risk assessment reports for 60 aromatic brominated flame-retardant substances. It delayed the compilation of the chromium VI substance restriction regulation to April 2025 and completed four authorization substance usage restriction screening reports.

          IndicatorsEstimateActual
          Restriction proposals or investigation/screening reports developed55
          Number of RAC and SEAC opinions on restriction proposals11

          7. Classification and Labelling

          In 2024, ECHA efficiently processed 60 chemical uniform classification proposals, with the RAC Committee approving 56 classification and labeling technical opinions. It achieved a milestone in CLP regulation revision.

          IndicatorsEstimateActual
          Proposals for harmonized classification and labeling5060
          Number of RAC opinions on proposals for harmonized classification and labeling5056
          Decisions made on requests to use an alternative chemical name (Art 24 CLP)4020

          ECHA upgraded the CLP regulation adaptation system, enabling smart connectivity between IUCLID data interfaces and notification portals.

          IndicatorsEstimateActual
          Poison centre notifications received and made available to Appointed Bodies and Poison Centres2 to 3 million3,148,898
          Poison centre notifications viewed by national authorities in the PCN central database15,00022,775

          8. Data Management and Dissemination

          In Q1 2024, ECHA launched ECHA CHEM 1.0, a new-generation chemical information platform, achieving full-scale public disclosure of REACH registration dossier data.

          9. Promotion of Alternatives to Animal Testing

          In 2024, ECHA achieved a dual-version iteration of QSAR Toolbox, completed full-function deployment of Meta Map, and integrated it with IUCLID 8.0. It led to the development of OECD omics-sampling international standards and initiated a revolutionary animal-testing alternative plan.

          10. Biocides

          In 2024, ECHA completed 15 active-substance opinions and one approval review opinion. It published 17 EU authorization opinions and 8 opinions requested by the EU Commission.

          IndicatorsEstimateActual
          Number of opinions on active substances [approval & renewal]1515
          Number of opinions on Union authorisation of biocidal products2017
          Number of opinions on Union authorisation and related processes: same biocidal products, administrative, minor, and major changes.3540
          Number of technical equivalence application assessments3032

          11. Prior Informed Consent

          In 2024, ECHA received and successfully processed 10,448 export notifications.

          IndicatorsEstimateActual
          Export notifications processed 11,00010,448
          Share of notifications validated by ECHA90%94%
          Support provided to PIC duty holders (importers and exporters) 250253

          12. Persistent Organic Pollutants

          In 2024, ECHA updated the scientific dossiers for siloxane-related substances (D4, D5, D6) and screened candidates for POPs – standard compliance.

          IndicatorsEstimateActual
          Number of scientific dossiers drafted for the identification of new substances as Persistent Organic Pollutants11
          Support provided to various stakeholders 5070
          Scientific and technical support provided to the Commission, EU, and non-EU CAs.1035

          Summary

          ECHA made significant progress in 2024, particularly in chemical safety, data transparency, and organizational development. Moving forward, it will continue to address emerging challenges, including supporting the EU's Green New Deal, promoting non - animal testing methods, and strengthening cooperation with member states and stakeholders.

          If you need any assistance or have any questions, please get in touch with us via service@cirs-group.com.

          Further Information

          ECHA

            

          We have launched a LinkedIn newsletter to keep you up to date on the latest developments across the chemical industry including food and FCMs and personal and home care.

          Contact Us
          +353 1 477 3710 (EU)
          +44 20 3239 9430 (UK)
          +1 703 520 1420 (USA)
          +86 571 8720 6574 (CN)
          +82 2 6347 8816 (KR)
          +81 070-9365-8022 (JP)
          1. <dfn id="8ngdu"></dfn>

            1. <dfn id="8ngdu"></dfn>
              <rp id="8ngdu"><address id="8ngdu"></address></rp>
                <video id="8ngdu"><menu id="8ngdu"><kbd id="8ngdu"></kbd></menu></video>

                1. <b id="8ngdu"></b>

                亚洲国产精品激情在线观看